atorvastatin
atorvastatin: sourced relationships with 2 companies · 12 clinical trials tracked · 5 FDA decisions.
atorvastatin evidence translation
What we can confirm
5 FDA records · 12 tracked trials
What it means
What to watch
Prepared research question
What is verified about atorvastatin, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence7 indications · 2 study sponsors
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| DR REDDYS LABORATORIES LTD (RDY) Reported 2012-07-17 · Current development: unknownSource | Approved |
| Teva Pharmaceutical Industries Limited (TEVA) Reported 2012-05-29 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (12)showing 10 most recent
A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of UBT251 on the Pharmacokinetics of Single Oral Doses of Metformin, Warfarin, Atorvastatin, and Digoxin in Overweight or Obese Participants.
Primary endpoint: Area under plasma concentration-time curve of metformin (AUC0-τ) and S-warfarin, R-warfarin (AUC0-t, AUC0-∞)
An Open-label, Fixed-sequence Study to Assess the Effect of Elecoglipron on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Participants
Primary endpoint: Area under concentration-time curve from time 0 to infinity (AUCinf) of atorvastatin
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Primary endpoint: Change in Glasgow Outcome Scale-Extended (GOSE 2-Way)
A Multi-Center, Randomized, Open-label, Parallel, Controlled Phase Ⅳ Clinical Trial to Evaluate the Effect of Inclisiran on Coronary Atherosclerotic Plaque in Patients With Acute Myocardial Infarction and Elevated Low-density Lipoprotein Cholesterol
Primary endpoint: Change in percent atheroma volume (PAV)
EpisodicStatinMig. A Multicentre, Triple Blind, Placebo Controlled, Parallel Group Study of Atorvastatin in Episodic Migraine
Primary endpoint: Number of migraine days
An Open-label, One-sequence Cross-over, Single-centre Trial, Investigating the Influence of CagriSema on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Atorvastatin in Participants With Overweight or Obesity
Primary endpoint: AUC0-72hours,atorv,SD: Area under the atorvastatin plasma concentration-time curve from time 0 to 72 hours after a single dose of atorvastatin without CagriSema exposure and at CagriSema steady state
A Study to Evaluate the Effect of Daily Doses of Obicetrapib Tablets on the Pharmacokinetics of Atorvastatin Calcium Tablets or Rosuvastatin Calcium Tablets in Healthy Adult Subjects
Primary endpoint: Measure atorvastatin/rosuvastatin levels in the blood
Vascular Endothelial Dysfunction in Sleep Apnea
Primary endpoint: Circulating levels of Angiopoietin-2 after 4 weeks of atorvastatin vs. placebo therapy
A Pilot Study of Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
Primary endpoint: Interference in pregnancy progress
Targeting Cerebrovascular Reactivity for Precision Medicine: Pilot Trial of Atorvastatin
Primary endpoint: Change of MRI whole brain cerebrovascular reactivity (wbCVR)
FDA Decisions5 records
Frequently asked questions
Which companies have sourced relationships with atorvastatin?
atorvastatin has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD, Teva Pharmaceutical Industries Limited.
How many clinical trials involve atorvastatin?
BioSniper tracks 12 clinical trials involving atorvastatin.
What is atorvastatin's latest FDA decision?
The most recent tracked FDA decision for atorvastatin is Approval, dated November 13, 2025.